Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

  • your selections
Clear Search

Filter Results

date

Topics

Tags

Content Type

  • results
  • state & global data
  • slides
The Henry J. Kaiser Family Foundation

Medicare Prescription Drug Improvement and Modernization Act Implementation Timeline: June 2004 – December 2006 Key Dates

Key Implementation Dates for the Medicare Prescription Drug BenefitThis timeline presents important dates and deadlines of key implementation activities related to the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA). It runs from the beginning of 2005 through the end of 2006, the first year of the new…

Report Read More
The Henry J. Kaiser Family Foundation

Low-Income Subsidies for the Medicare Prescription Drug Benefit: The Impact of the Asset Test

This study assesses the impact of the requirement that low-income people with Medicare meet an asset test in order to receive additional help paying premiums and cost-sharing under the new Medicare drug benefit.Report (.pdf)American Journal of Managed Care Article: Who Will Be Denied Medicare Prescription Drug Subsidies Because of the…

Report Read More
The Henry J. Kaiser Family Foundation

Profile and Analysis of the 26 Medicare Advantage Regions

This issue brief examines the 26 new Medicare Advantage PPO regions and their implications for beneficiaries. The paper describes the characteristics of the new Medicare Advantage regions and the extent to which Medicare Advantage plans are already available in each region. It highlights the substantial gap between the current availability…

Issue Brief Read More
The Henry J. Kaiser Family Foundation

Summary of Final Regulations Implementing the New Medicare Prescription Drug Benefit

This document summarizes the final regulations to implement the new Medicare prescription drug benefit. The regulations were published by the Centers for Medicare and Medicaid Services (CMS) as a final rule in the Jan. 28 Federal Register. It provides an overview that allows interested parties to obtain information about specific…

Issue Brief Read More
The Henry J. Kaiser Family Foundation

Summary of the Proposed Rule to Implement the New Medicare Prescription Drug Benefit

In August 2004, the Centers for Medicare and Medicaid Services published a proposed rule to implement the Medicare Prescription Drug Benefit (Title I of the Medicare Modernization Act). Given the high level of interest in the proposed rules for implementing the Medicare drug benefit, the Kaiser Family Foundation commissioned Health…

Issue Brief Read More
The Henry J. Kaiser Family Foundation

Prescription Drug Spending Under The MMA: Modeling The Impact On Out-of-Pocket Costs

This report projects the impact of the new Medicare drug benefit on out-of-pocket spending for people who enroll in 2006. The analysis is based on a model developed by the Actuarial Research Corporation for the Kaiser Family Foundation. The model generally conforms to the Congressional Budget Office’s assumptions and projections…

Event Read More
The Henry J. Kaiser Family Foundation

Estimates of Medicare Beneficiaries’ Out-of-Pocket Drug Spending in 2006

This report projects the impact of the new Medicare drug benefit on out-of-pocket spending for people who enroll in 2006. This analysis from November 2004 estimates that 6.9 million beneficiaries are projected to be affected by the coverage gap (the so-called “doughnut hole”) in the standard Part D drug benefit.…

Report Read More
The Henry J. Kaiser Family Foundation

Marketing and Privacy Issues: An Analysis of the MMA and Proposed Regulations

This paper, by Joy Pritts of the Health Policy Institute at Georgetown University, looks at issues related to drug plan marketing activities and privacy under the MMA.Issue Brief (.pdf)

Issue Brief Read More
The Henry J. Kaiser Family Foundation

Grievance and Appeals Procedures: An Analysis of the MMA and Proposed Regulations

This paper, by Sara Rosenbaum, J.D., Director of the Center for Health Services Research and Policy at George Washington University, examines the procedures for resolving beneficiaries' grievances and appeals under the new Medicare drug benefit. It is one in a series commissioned by the Kaiser Family Foundation that analyzes issues…

Issue Brief Read More
The Henry J. Kaiser Family Foundation

Issues for Medicare Beneficiaries in Long-Term Care Facilities: An Analysis of the MMA and Proposed Regulations

This paper, by Vicki Gottlich, J.D., of the Center for Medicare Advocacy, looks at issues related to the new Medicare prescription drug benefit for people with Medicare who live in nursing homes or other long-term-care settings. It is one in a series commissioned by the Kaiser Family Foundation that analyzes…

Issue Brief Read More